© 2024 Texas Public Radio
Real. Reliable. Texas Public Radio.
Play Live Radio
Next Up:
0:00 0:00
Available On Air Stations

Judge Bars Texas’ Anti-Telemedicine Rules From Taking Effect

Source: Teladoc

DALLAS — A federal judge has determined claims made by the Texas Medical Board in adopting new telemedicine rules were “suspect” and barred the rules from taking effect until a civil trial can be held in lower court.

The ruling by U.S. District Judge Robert Pitman hinges largely on a revised rule the board adopted in April that requires a patient to have a “face-to-face visit or in-person evaluation” before a prescription can be dispensed. The board has argued such a measure is crucial to ensuring patient safety and quality care.

But Dallas-based Teladoc, which challenged the board’s action, argued the panel violated federal antitrust laws because the rule significantly impairs its business model.

Teladoc, one of the leading telemedicine providers in the U.S., offers a network in Texas in which a patient consults by phone with a physician and then can upload over the Internet or by mobile app images or other medical data, Teladoc spokeswoman Meredith Adams said. The new revisions would damage this service by first requiring a face-to-face examination, Adams said.

Lawyers for the board had argued during a May hearing that Teladoc was being speculative when it argued the new rules would lead to increased prices for patients, fewer choices and other drawbacks.

“The court disagrees,” Pitman said in his ruling. “Plaintiffs’ evidence shows the average costs of visits to a physician or emergency room are $145 and $1,957, respectively, and the cost for a Teladoc consultation is typically $40.” Pitman also determined the board’s arguments against Teladoc were “poorly founded.”

A board spokeswoman said Monday the agency isn't commenting on the ruling. In a statement last month, board president Dr. Michael Arambula said the board wants to avoid any sort of initial treatment done by telephone that doesn’t provide “any objective diagnostic data” to help a doctor serve a patient.

“The board recognizes that as technology evolves, so too must regulations governing telemedicine,” Arambula said. No trial date has been scheduled for Teladoc's lawsuit.

Teladoc CEO Jason Gorevic said telehealth is an important part of health care in Texas, where many rural regions have few doctors and it can be difficult for patients to travel long distances to medical centers.

Teladoc operates in 48 states and hasn't encountered the kind of legal tussles that have transpired in Texas, Gorevic said. “Texas is an outlier. We have not ended up in court in any other state,” he said. “This represents the sixth time that the courts have found in our favor in Texas.”

Lawyers for the board said in May that it’s critical for a patient to have an established relationship with a physician, arguing that treatment notes are more likely to become part of the patient's “permanent medical record” than if they were provided by a Teladoc consulting physician.

But Pitman said in reality patients do not have a single medical record, and instead have records scattered across a variety of providers. Adams added, “Physicians have been practicing telehealth for decades by covering for one another on call.” (AP)